Mounjaro vs Zepbound: Same Drug, Different Uses

How the medications work

These medications act on incretin pathways that influence glucose regulation, appetite and digestion. Semaglutide is a GLP-1 receptor agonist. Tirzepatide activates both GIP and GLP-1 receptors. Products with the same active ingredient can still have different FDA-approved indications, devices and dose schedules.

Weight-loss expectations

Clinical-trial averages are useful for understanding a population, not predicting an individual. Results depend on the product, dose reached, treatment duration, starting characteristics, adherence and the trial’s design. Some participants lose more than average, some less, and some stop because of side effects.

Side effects and safety

Common adverse effects include nausea, diarrhea, vomiting, constipation and abdominal discomfort. Product labels also describe less common but serious risks and contraindications. Both semaglutide and tirzepatide product labels include boxed warnings related to thyroid C-cell tumors observed in rodents; the relevance to humans is unknown. Review the current label and your personal and family history with a prescriber.

Cost, savings and insurance

Cash prices, formularies and manufacturer programs change. Coverage often follows the FDA-approved indication: a plan may cover a diabetes product for type 2 diabetes while excluding weight-management medication. Before enrolling in care, confirm the medication price, program fee, laboratory costs, prior-authorization support, renewal fee and cancellation terms.

How clinicians choose

A prescriber may review diagnosis, body-mass index where relevant, weight-related conditions, glucose and kidney measures, gastrointestinal history, pregnancy plans, current medications, prior treatment, eating-disorder history and your ability to follow up. The most effective option on paper is not always the most appropriate or accessible option for one person.